NON RARE IN EUROPE: Post-herpetic neuralgia Advocacy Hub | UniteRare

At a Glance

Live from database

💊

Regulatory Watchboard

10 events

Feb 2026

GABAPENTIN: New indication approved

FDAcompleted

Jan 2026

GABAPENTIN: New indication approved

FDAcompleted

Apr 2025Esketamine Combined With PRF for Trigeminal Postherpetic Neuralgia

Beijing Tiantan Hospital — NA

TrialNOT YET RECRUITING

Jan 2025

GABAPENTIN: New indication approved

FDAcompleted

Dec 2024

GABAPENTIN: New indication approved

FDAcompleted

Jul 2024The Treatment of Postherpetic Neuralgia in the Head and Face With Superficial Needling Combined With Electroacupuncture

Zhejiang Chinese Medical University — NA

TrialRECRUITING

Mar 2024Predictive Models for the Treatment of Recurrent Herpes Zoster Neuralgia Following Spinal Cord Electrical Stimulation.

Feng Gao

TrialENROLLING BY INVITATION

Feb 2024The Efficacy of High-frequency Short-time Spinal Cord Stimulation in the Treatment of Herpes Zoster-associated Neuralgia

Li Zhao

TrialRECRUITING

Feb 2023Clinical Trial of the Safety and Efficacy of Peripheral Nerve Stimulation in the Treatment of Peripheral Neuropathic Pain.

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology — NA

TrialRECRUITING

Nov 2022A MAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers and PHN Patients.

iN Therapeutics Co., Ltd. — PHASE1

TrialRECRUITING

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

1 program

FINANCIAL LANDSCAPE SUMMARY

Total programs

Open now

Copay cards

Copay Assistance1

GABAPENTIN

Pfizer

OpenContact for detailsApply ↗

View all support programs on disease page →

Approved Treatments

4 FDA-approved

Horizant

(gabapentin enacarbil)Orphan drug

Arbor Pharmaceuticals, LLC

12.1 Mechanism of Action Gabapentin enacarbil is a prodrug of gabapentin and, accordingly, its therapeutic effects in RLS and PHN are attributable to ...

Approved Jun 2012FDA label ↗

Gralise

(gabapentin)Orphan drug

Golf Acquiror LLC

12.1 Mechanism of Action The mechanism of action by which gabapentin exerts its analgesic action is unknown but in animal models of analgesia, gabapen...

Approved Jan 2011FDA label ↗

Qutenza

(capsaicin)Orphan drug

Averitas Pharma, Inc.

12.1 Mechanism of Action Capsaicin is an agonist for the transient receptor potential vanilloid 1 receptor (TRPV1), which is an ion channel-receptor c...

Approved Nov 2009FDA label ↗

Lidoderm Patch

(Lidocaine patch 5%)Orphan drugstandard

Teikoku Pharma USA, Inc.

Amide Local Anesthetic [EPC]

FDA label ↗

View full treatment details on disease page →